SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-23-117241
Filing Date
2023-11-13
Accepted
2023-11-13 16:20:39
Documents
4
Period of Report
2023-12-12

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2328245-4_def14a.htm DEF 14A 244035
2 GRAPHIC lg_firstwavebiopharma-4c.jpg GRAPHIC 44083
3 GRAPHIC px_23waveproxy01pg01-bw.jpg GRAPHIC 343459
4 GRAPHIC px_23waveproxy01pg02-bw.jpg GRAPHIC 392923
  Complete submission text file 0001104659-23-117241.txt   1320428
Mailing Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431
Business Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431 561-589-7020
First Wave BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 464993860 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37853 | Film No.: 231399089
SIC: 2834 Pharmaceutical Preparations